NCT06903962

Brief Summary

The goal of this nonrandomized pilot study is to test a mind-body interventional approach for the treatment of chronic upper extremity pain or repetitive stress injury of the upper extremity (wrist/shoulder/elbow).

  1. 1.To determine if a mind-body intervention improves upper extremity functional capacity (ie., Disability of Arm Shoulder Hand - DASH) among people with chronic wrist, elbow, and shoulder pain
  2. 2.To determine if a mind-body intervention decreases pain intensity, pain-related anxiety, and overall somatic complaints in our trial participants.
  3. 3.To tailor the intervention and the outcomes assessment procedures for conducting a trial in a population with upper extremity pain.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable chronic-pain

Timeline
13mo left

Started Mar 2025

Typical duration for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Mar 2025Jun 2027

First Submitted

Initial submission to the registry

March 26, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

March 28, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 1, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

1.8 years

First QC Date

March 26, 2025

Last Update Submit

February 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Disabilities of the Arm, Shoulder, and Hand Questionnaire (DASH)

    The DASH is a commonly used and validated 38 question survey self-report survey assessing the effects of upper extremity disabling conditions on functional activity, pain, sleep, and other parameters

    Baseline, 4 weeks, 8 weeks, 13 weeks

Secondary Outcomes (4)

  • Upper Extremity Function Scale

    Baseline, 4 weeks, 8 weeks, 13 weeks

  • Brief Pain Inventory Questionnaire (Short Form)

    Baseline, 4 weeks, 8 weeks, 13 weeks

  • Pain Anxiety Symptom Scale (short form 20)

    Baseline, 4 weeks, 8 weeks, 13 weeks

  • Somatic Symptom Score (SSS-8)

    Baseline, 4 weeks, 8 weeks, 13 weeks

Study Arms (1)

Experimental: Mind-body Intervention

EXPERIMENTAL

Mind body techniques for the intervention will be taught in lectures and group discussion sessions

Behavioral: Mind-Body Intervention

Interventions

The mind-body intervention will include regular approximate 2 hour educational sessions and didactics learning mind body techniques. The sessions will be twice per week for the first 4 weeks and then subsequently once per week for a total of 13 weeks.

Experimental: Mind-body Intervention

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult (≥ 18 years of age)
  • A disability score ≥ 40 as per the QuickDASH survey
  • Presence of pain and perceived disability for a minimum of 3 months
  • Willing to engage in a Mind-Body intervention
  • Positive visualization test (onset of pain when patients visualize themselves performing tasks that generally bring on pain)

You may not qualify if:

  • Clear organic diagnosis of pain (e.g., cancer, infection, etc…) not inclusive of non-specific findings on imaging studies (e.g., mild arthritis)
  • Age greater than 60 years (due to an increased risk of there being an organic/physical cause for their pain and confounding results)
  • Diagnosis of cognitive impairment or dementia
  • Active addiction disorder, e.g. cocaine or IV heroin use, that would interfere with study participation
  • Major psychiatric comorbidity (e.g., schizophrenia). Anxiety and mild-moderate depression are not considered in this category

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02115, United States

RECRUITING

MeSH Terms

Conditions

Chronic PainCumulative Trauma Disorders

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSprains and StrainsWounds and Injuries

Study Officials

  • Michael Donnino, MD

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This is a cohort study in which all participants will receive the mind-body intervention. We will not modify participant medication regimens and no pain or other medication prescriptions will be issued by the research team at any time
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Emergency Medicine

Study Record Dates

First Submitted

March 26, 2025

First Posted

April 1, 2025

Study Start

March 28, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

June 1, 2027

Last Updated

February 18, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations